LFST icon

Lifestance Health

6.63 USD
-0.03
0.45%
At close Apr 1, 3:59 PM EDT
After hours
6.63
+0.00
0.00%
1 day
-0.45%
5 days
-2.36%
1 month
-16.18%
3 months
-12.19%
6 months
-3.77%
Year to date
-12.19%
1 year
6.94%
5 years
-69.73%
10 years
-69.73%
0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

474% more call options, than puts

Call options by funds: $44.7M | Put options by funds: $7.77M

171% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 14

79% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 34

18% more funds holding

Funds holding: 130 [Q3] → 153 (+23) [Q4]

8% more capital invested

Capital invested by funds: $2.3B [Q3] → $2.48B (+$178M) [Q4]

1.97% more ownership

Funds ownership: 86.01% [Q3] → 87.98% (+1.97%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for LFST.

Financial journalist opinion

Negative
Zacks Investment Research
1 week ago
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Neutral
Seeking Alpha
1 month ago
LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ken Burdick - CEO David Bourdon - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrea Alfonso - UBS Operator Thank you for standing by. My name is Danielle, and I will be your conference operator today.
LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates
LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.12 per share a year ago.
LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates
Neutral
PRNewsWire
1 month ago
LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman
Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz. , Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (Nasdaq: LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer.
LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman
Neutral
GlobeNewsWire
1 month ago
LifeStance Reports Fourth Quarter and Full Year 2024 Results
SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2024.
LifeStance Reports Fourth Quarter and Full Year 2024 Results
Negative
Zacks Investment Research
1 month ago
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LifeStance Health Group (LFST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Neutral
GlobeNewsWire
1 month ago
LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025
SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025.
LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025
Positive
Zacks Investment Research
2 months ago
Best Momentum Stocks to Buy for January 29th
EAT, LFST and MC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 29, 2024.
Best Momentum Stocks to Buy for January 29th
Positive
Zacks Investment Research
2 months ago
New Strong Buy Stocks for January 29th
MC, LFST, EAT, CYRX and HCP have been added to the Zacks Rank #1 (Strong Buy) List on January 29, 2024.
New Strong Buy Stocks for January 29th
Positive
Zacks Investment Research
2 months ago
LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know
LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LifeStance Health (LFST) Upgraded to Strong Buy: Here's What You Should Know
Charts implemented using Lightweight Charts™